Compare · HCXY vs PPH
HCXY vs PPH
Side-by-side comparison of Hercules Capital, Inc. (HCXY) and VanEck Vectors Pharmaceutical ETF (PPH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HCXY and PPH operate in n/a (n/a), so they compete in similar markets.
- HCXY carries a market cap of $4.49B.
- Over the past year, HCXY is up 0.6% and PPH is up 25.1% - PPH leads by 24.5 points.
- HCXY has hit the wire 3 times in the past 4 weeks while PPH has been quiet.
VanEck Vectors Pharmaceutical ETF
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Latest HCXY
- Hercules Capital Closes Institutional Notes Offering of $325.0 Million 6.300% Unsecured Notes due 2031
- Hercules Capital Prices Institutional Notes Offering of $325.0 Million 6.300% Notes due 2031
- Hercules Capital Announces Date for Release of Second Quarter 2026 Financial Results and Conference Call
- Hercules Capital Announces Date of 2026 Annual Meeting of Stockholders
- Hercules Capital Reports First Quarter 2026 Financial Results
- Hercules Capital Enters Next Phase of Growth with Expanded Leadership Team
- Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2026
- Hercules Capital Announces Date for Release of First Quarter 2026 Financial Results and Conference Call
- Hercules Capital Sets New Record with All-Time High New Debt and Equity Commitments
- Hercules Capital Receives a BBB (high) Affirmed Investment Grade Corporate and Credit Rating from Morningstar DBRS
Latest PPH
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- Ozempic Maker Novo Nordisk Closes In On Lego As Denmark's Most Valuable Brand: Report
- Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage
- 11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
- Biden-Harris Administration Moves Forward with Medicare Drug Price Negotiations to Lower Prescription Drug Costs for People with Medicare